The Latest
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. – ADMA
ClaimsFiler reminds investors with losses over $100,000 about the lead plaintiff deadline in the ADMA Biologics class action lawsuit.